A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling

Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells

(2012) Sangkil Nam et al.   Molecular Oncology

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

(2011) J. PosthumaDeBoer et al.   CLINICAL & EXPERIMENTAL METASTASIS

Osteosarcoma

(2010) J. Ritter et al.   ANNALS OF ONCOLOGY

Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells

(2010) Jiunn-Min Shieh et al.   BRITISH JOURNAL OF PHARMACOLOGY

AP-1 — The Jun proteins: Oncogenes or tumor suppressors in disguise?

(2010) Eitan Shaulian   CELLULAR SIGNALLING

Stratifying Osteosarcoma: Minimizing and Maximizing Therapy

(2010) Lisa M. Niswander et al.   Current Oncology Reports

Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells

(2009) Yun Liang et al.   ACTA PHARMACOLOGICA SINICA

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Suppression of human lung cancer cell growth and migration by berbamine

(2009) Huiying Duan et al.   CYTOTECHNOLOGY

Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice

(2009) Guan-Yu Wang et al.   JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action

(2009) Shan Wang et al.   Molecular Cancer

BAD: undertaker by night, candyman by day

(2009) N N Danial   ONCOGENE

JNK signaling in apoptosis

(2008) D N Dhanasekaran et al.   ONCOGENE